Altana sees 6 pct sales and profit growth in 2007, sales up 10 pct in future |
|
|
|
Published
:
Wed, 24 Jan 2007 11:04
|
FRANKFURT (AFX) - Altana AG expects annual organic growth rates of 6 pct following the sale of its pharma operations, future group CEO and current Altana Chemie head Matthias Wolfgruber told Financial Times Deutschland.Not taking possible acquisitions into account, sales and profit are expected to increase by about 6 pct this year, Wolfgruber said, adding that in the future sales are seen increasing by 10 pct annually.Wolfgruber also said, should the US SEC amend its rules, and allow companies with a US trading volume of less than 5 pct of the volume on the company's home market to de-register from US stock exchanges, it will do so immediately.Altana sold its pharmaceutical operations to Danish company Nycomed Holding AS last year.newsdesk@afxnews.comjcs/jfrCOPYRIGHTCopyright AFX News Limited 2006. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Altana Chemie confirms FY sales and EBITDA outlook 